Company Description
The nexus of intercellular communication is protein and Adnexus plans to capitalize on that. The company makes protein-based drugs called...
Key Adnexus Therapeutics Financials
| Company Type | Subsidiary of Bristol-Myers Squibb - Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $0.3 |
| 2006 Employees | 58 |
More Adnexus Therapeutics Financials (4 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is...
Read more about Adnexus Therapeutics's competition across multiple industries
Top Adnexus Therapeutics Competitors
Sponsored Links
The Business Directory
Adnexus Therapeutics Executives
| Title | Name & Bio | Contact |
|---|---|---|
| VP Business Development | Katrine S. Bosley | Network | E-mail |
| President | John B. Edwards | Network | E-mail |
| Financial Consultant and Interim Chief Financial Officer | Lorin J. (Jeff) Randall | Network | E-mail |
More Adnexus Therapeutics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Adnexus Therapeutics News
Sponsored Opportunity
